Skip to content

Full-wrap Suspension versus Double-Strap Suspension for Reducing the Incidence of Soft Palate Injury: A Prospective Multi-center Randomized Controlled Trial

Full-wrap Suspension versus Double-Strap Suspension for Reducing the Incidence of Soft Palate Injury: A Prospective Multi-center Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123851
Enrollment
Unknown
Registered
2026-04-30
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study enrolls patients requiring transoral pharyngeal surgery for the following conditions: adenoid hypertrophy (manifested as nasal obstruction, mouth breathing, and snoring during sleep)

Interventions

Control Group:Intraoperative soft palate suspension using the double-strap method.
Experimental Group:Intraoperative soft palate suspension using the full-wrap method.

Sponsors

Fifth Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Voluntarily sign the informed consent form; for patients aged <18 years, the informed consent form must be signed by their legal guardian. 2.Age between 2 and 70 years (inclusive), male or female. 3.Patients requiring transoral surgery of the nose, pharynx, parapharyngeal space, or skull base, in which intraoperative soft palate suspension is needed. 4.Intact soft palate mucosa with no ulcers, scars, or other lesions before surgery.

Exclusion criteria

Exclusion criteria: 1.Congenital cleft palate or submucous cleft palate. 2.Patients with limited cervical spine mobility, micrognathia, or other conditions affecting surgical exposure. 3.Pregnant or breastfeeding women. 4.Presence of markedly abnormal laboratory test results, such as significant abnormalities in routine blood tests, blood biochemistry, liver and kidney function, or coagulation function. 5.Patients with active infection or infectious diseases. 6.Severe cardiac insufficiency (NYHA class III-IV). 7.Other conditions deemed unsuitable for surgery after evaluation (e.g., concomitant severe heart, brain, or lung diseases; high anesthetic risk; patients not fit for surgery).

Design outcomes

Primary

MeasureTime frame
Incidence of device-related adverse events;Incidence of soft palate injury;

Secondary

MeasureTime frame
Incidence of serious adverse events (SAE);Postoperative VAS pain score;System Usability Scale (SUS) score;Incidence of complications not related to soft palate injury;Proportion of surgery interruption or early termination;Incidence of postoperative infection or fever;Healing time of soft palate injury;

Countries

China

Contacts

Public ContactChen Mingyuan

Fifth Affiliated Hospital, Sun Yat-Sen University

chenmy@sysucc.org.cn+86 20 87342422

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026